183 related articles for article (PubMed ID: 18287568)
1. TNFRSF1A R92Q mutation in association with a multiple sclerosis-like demyelinating syndrome.
Hoffmann LA; Lohse P; König FB; Feneberg W; Hohlfeld R; Kümpfel T
Neurology; 2008 Mar; 70(13 Pt 2):1155-6. PubMed ID: 18287568
[No Abstract] [Full Text] [Related]
2. X-linked Charcot-Marie-Tooth disease and progressive-relapsing central demyelinating disease.
Isoardo G; Di Vito N; Nobile M; Benetton G; Fassio F
Neurology; 2005 Nov; 65(10):1672-3. PubMed ID: 16301507
[No Abstract] [Full Text] [Related]
3. Progressive megalencephaly due to specific EIF2Bepsilon mutations in two unrelated families.
Passemard S; Gelot A; Fogli A; N'Guyen S; Barnerias C; Niel F; Doummar D; Arbues AS; Mignot C; de Villemeur TB; Ponsot G; Boespflug-Tanguy O; Rodriguez D
Neurology; 2007 Jul; 69(4):400-2. PubMed ID: 17646634
[No Abstract] [Full Text] [Related]
4. Demyelinating disease of central and peripheral nervous systems associated with a A8344G mutation in tRNALys.
Erol I; Alehan F; Horvath R; Schneiderat P; Talim B
Neuromuscul Disord; 2009 Apr; 19(4):275-8. PubMed ID: 19269823
[TBL] [Abstract][Full Text] [Related]
5. Late-onset tumor necrosis factor receptor-associated periodic syndrome in multiple sclerosis patients carrying the TNFRSF1A R92Q mutation.
Kümpfel T; Hoffmann LA; Rübsamen H; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P
Arthritis Rheum; 2007 Aug; 56(8):2774-83. PubMed ID: 17665448
[TBL] [Abstract][Full Text] [Related]
6. Central nervous system involvement in hereditary neuropathy with liability to pressure palsies: description of a large family with this association.
Sanahuja J; Franco E; Rojas-García R; Gallardo E; Combarros O; Begué R; Granés P; Illa I
Arch Neurol; 2005 Dec; 62(12):1911-4. PubMed ID: 16344349
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 cases.
Kümpfel T; Hoffmann LA; Pellkofer H; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P
Neurology; 2008 Nov; 71(22):1812-20. PubMed ID: 19029521
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis-like disorder in OPA1-related autosomal dominant optic atrophy.
Verny C; Loiseau D; Scherer C; Lejeune P; Chevrollier A; Gueguen N; Guillet V; Dubas F; Reynier P; Amati-Bonneau P; Bonneau D
Neurology; 2008 Mar; 70(13 Pt 2):1152-3. PubMed ID: 18287570
[No Abstract] [Full Text] [Related]
9. Hereditary leukodystrophies without identified mutations.
Robitaille Y
J Neurol Sci; 2005 Feb; 228(2):208-9. PubMed ID: 15694209
[No Abstract] [Full Text] [Related]
10. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment.
Stojanov S; Dejaco C; Lohse P; Huss K; Duftner C; Belohradsky BH; Herold M; Schirmer M
Ann Rheum Dis; 2008 Sep; 67(9):1292-8. PubMed ID: 18180277
[TBL] [Abstract][Full Text] [Related]
11. Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome with stroke-like imaging presentation: clinical, biochemical and molecular analysis.
Al-Hassnan ZN; Rashed MS; Al-Dirbashi OY; Patay Z; Rahbeeni Z; Abu-Amero KK
J Neurol Sci; 2008 Jan; 264(1-2):187-94. PubMed ID: 17825324
[TBL] [Abstract][Full Text] [Related]
12. TNFRSF1A coding variants in multiple sclerosis.
Goris A; Fockaert N; Cosemans L; Clysters K; Nagels G; Boonen S; Thijs V; Robberecht W; Dubois B
J Neuroimmunol; 2011 Jun; 235(1-2):110-2. PubMed ID: 21565411
[TBL] [Abstract][Full Text] [Related]
13. The tumor-necrosis-factor-associated periodic syndrome, the brain, and tumor-necrosis-factor-alpha antagonists.
Wildemann B; Rudofsky G; Kress B; Jarius S; Konig F; Schwenger V
Neurology; 2007 May; 68(20):1742-4. PubMed ID: 17360963
[No Abstract] [Full Text] [Related]
14. Novel SACS mutation in a Belgian family with sacsin-related ataxia.
Ouyang Y; Segers K; Bouquiaux O; Wang FC; Janin N; Andris C; Shimazaki H; Sakoe K; Nakano I; Takiyama Y
J Neurol Sci; 2008 Jan; 264(1-2):73-6. PubMed ID: 17716690
[TBL] [Abstract][Full Text] [Related]
15. Association of the R92Q TNFRSF1A mutation and extracranial deep vein thrombosis in patients with Behçet's disease.
Amoura Z; Dodé C; Hue S; Caillat-Zucman S; Bahram S; Delpech M; Grateau G; Wechsler B; Piette JC
Arthritis Rheum; 2005 Feb; 52(2):608-11. PubMed ID: 15692984
[TBL] [Abstract][Full Text] [Related]
16. Pseudodominant inheritance of spastic ataxia of Charlevoix-Saguenay.
Terracciano A; Foulds NC; Ditchfield A; Bunyan DJ; Crolla JA; Huang S; Santorelli FM; Hammans SR
Neurology; 2010 Apr; 74(14):1152-4. PubMed ID: 20368637
[No Abstract] [Full Text] [Related]
17. A novel splice site mutation in the Cockayne syndrome group A gene in two siblings with Cockayne syndrome.
Kleppa L; Kanavin ØJ; Klungland A; Strømme P
Neuroscience; 2007 Apr; 145(4):1397-406. PubMed ID: 17084038
[TBL] [Abstract][Full Text] [Related]
18. A novel duplication confirms the involvement of 5q23.2 in autosomal dominant leukodystrophy.
Meijer IA; Simoes-Lopes AA; Laurent S; Katz T; St-Onge J; Verlaan DJ; Dupré N; Thibault M; Mathurin J; Bouchard JP; Rouleau GA
Arch Neurol; 2008 Nov; 65(11):1496-501. PubMed ID: 19001169
[TBL] [Abstract][Full Text] [Related]
19. Delta32 polymorphism of the chemokine receptor CCR5 in a patient with multifocal motor neuropathy.
Trebst C; Heiken H; Schmidt RE; Windhagen A; Stangel M
Muscle Nerve; 2007 Apr; 35(4):541-2. PubMed ID: 17266130
[No Abstract] [Full Text] [Related]
20. Global brain dysmyelination with above-average verbal skills in 18q- syndrome with a 17 Mb terminal deletion.
Netzer C; Helmstaedter C; Ehrbrecht A; Engels H; Schwanitz G; Urbach H; Schröder R; Weber RG; Kornblum C
Acta Neurol Scand; 2006 Aug; 114(2):133-8. PubMed ID: 16867037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
